Gynecol Obstet Fertil Senol. 2020 May;48(5):436-443. doi: 10.1016\/j.gofs.2020.03.014.<\/p>\n\n\n\n
Un nouveau coronavirus (SARS-CoV-2) mis en \u00e9vidence en fin d\u2019ann\u00e9e 2019 en Chine se diffuse \u00e0 travers tous les continents. Le plus souvent \u00e0 l\u2019origine d\u2019un syndrome infectieux sans gravit\u00e9, associant \u00e0 diff\u00e9rents degr\u00e9s des sympt\u00f4mes b\u00e9nins (fi\u00e8vre, toux, myalgies, c\u00e9phal\u00e9es et \u00e9ventuels troubles digestifs) le SARS-Covid-2 peut \u00eatre \u00e0 l\u2019origine de pathologies pulmonaires graves et parfois de d\u00e9c\u00e8s. Les donn\u00e9es sur les cons\u00e9quences pendant la grossesse sont limit\u00e9es. Les premi\u00e8res donn\u00e9es chinoises publi\u00e9es semblent montrer que les sympt\u00f4mes chez la femme enceinte sont les m\u00eames que ceux de la population g\u00e9n\u00e9rale. mais il y a un risque qu’il y ai plus de formes graves. Il n\u2019y a pas de cas de transmission maternof\u0153tale intra ut\u00e9rine mais des cas de nouveau-n\u00e9s infect\u00e9s pr\u00e9cocement font penser qu\u2019il pourrait y avoir transmission verticale per-partum ou n\u00e9onatale. Une pr\u00e9maturit\u00e9 induite et des cas de d\u00e9tresses respiratoires chez les nouveau-n\u00e9s de m\u00e8res infect\u00e9es ont \u00e9t\u00e9 d\u00e9crits. La grossesse est connue comme une p\u00e9riode plus \u00e0 risque pour les cons\u00e9quences des infections respiratoires, comme pour la grippe, il parait donc important de d\u00e9pister le Covid-19 en pr\u00e9sence de sympt\u00f4mes et de surveiller de fa\u00e7on rapproch\u00e9e les femmes enceintes infect\u00e9es. Dans ce contexte d\u2019\u00e9pid\u00e9mie de SARS-Covid-2, les soci\u00e9t\u00e9s savantes de gyn\u00e9cologie-obst\u00e9trique, d\u2019infectiologie et de n\u00e9onatalogie ont propos\u00e9 un protocole fran\u00e7ais de prise en charge des cas possibles et av\u00e9r\u00e9s de SARS-Covid-2 chez la femme enceinte. Ces propositions peuvent \u00e9voluer de fa\u00e7on quotidienne avec l\u2019avanc\u00e9e de l\u2019\u00e9pid\u00e9mie et des connaissances chez la femme enceinte.<\/p>\n\n\n\n
A new coronavirus (SARS-CoV-2) highlighted at the end of 2019 in China is spreading across all continents. Most often at the origin of a mild infectious syndrome, associating mild symptoms (fever, cough, myalgia, headache and possible digestive disorders) to different degrees, SARS-Covid-2 can cause serious pulmonary pathologies and sometimes death. Data on the consequences during pregnancy are limited. The first Chinese data published seem to show that the symptoms in pregnant women are the same as those of the general population. There are no cases of intrauterine maternal-fetal transmission, but cases of newborns infected early suggest that there could be vertical perpartum or neonatal transmission. Induced prematurity and cases of respiratory distress in newborns of infected mothers have been described. Pregnancy is known as a period at higher risk for the consequences of respiratory infections, as for influenza, so it seems important to screen for Covid-19 in the presence of symptoms and to monitor closely pregnant women. In this context of the SARS-Covid-2 epidemic, the societies of gynecology-obstetrics, infectious diseases and neonatalogy have proposed a French protocol for the management of possible and proven cases of SARS-Covid-2 in pregnant women. These proposals may evolve on a daily basis with the advancement of the epidemic and knowledge in pregnant women. Subsequently, an in-depth analysis of cases in pregnant women will be necessary in order to improve knowledge on the subject.<\/p>\n","protected":false},"excerpt":{"rendered":"
Gynecol Obstet Fertil Senol. 2020 May;48(5):436-443. doi: 10.1016\/j.gofs.2020.03.014.<\/p>\n","protected":false},"featured_media":0,"template":"","class_list":["post-1742","publication","type-publication","status-publish","hentry"],"yoast_head":"\n